Key result
Cardiac troponin I elevation accurately predicted short-term outcomes (AUC 0.741, p<0.001) and 6-month outcomes (AUC 0.688, p=0.015) in patients with aneurysmal subarachnoid haemorrhage.
Why the study?
Are cardiac troponin elevations and pulmonary disorders associated with short- and long-term outcomes in patients with aneurysmal subarachnoid haemorrhage?
Cohort (n=104)
Are cardiac troponin elevations and pulmonary disorders associated with short- and long-term outcomes in patients with aneurysmal subarachnoid haemorrhage?
Effect estimate: AUC 0.741
p-value: p=<0.001
Cardiac troponin elevation and pulmonary disorders are significant predictors of short- and medium-term clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.
Troponin I elevation may aid risk stratification in aneurysmal subarachnoid haemorrhage; leaves open whether it should guide management pending prospective validation.
Subject: Cardiopulmonary abnormalities are common after aneurysmal subarachnoid haemorrhage (aSAH). However, the relationship between short- and long-term outcome is poorly understood. In this paper, we present how cardiac troponine elevations (cTnI) and pulmonary disorders are associated with short- and long-term outcomes assessed by the Glasgow Outcome Scale (GOS) and Extended Glasgow Outcome Scale (GOSE).Methods: A total of 104 patients diagnosed with aSAH were analysed in the study. The non-parametric U Mann-Whitney test was used to evaluate the difference between good (GOS IV-V, GOSE V-VIII) and poor (GOS I-III, GOSE I-IV) outcomes in relation to cTnI elevation and pulmonary disorders. Outcome was assessed at discharge from the hospital, and then followed up 6 and 12 months later. Pulmonary disorders were determined by the PaO2/FiO2 ratio and radiography. The areas under the ROC curves (AUCs) were used to determine the predictive power of these factors.Results: In the group with good short-term outcomes cTnI elevation on the second day after aSAH was significantly lower (p = .00007) than in patients with poor short-term outcomes. The same trend was observed after 6 months, although there were different results 12 months from the onset (p = .024 and n.s., respectively). A higher peak of cTnI was observed in the group with a pathological X-ray (p = .008) and pathological PaO2/FiO2 ratio (p ≪ .001). cTnI was an accurate predictor of short-term outcomes (AUC = 0.741, p ≪ .001) and the outcome after 6 months (AUC = 0.688, p = .015).Conclusion: The results showed that cardiopulmonary abnormalities perform well as predictive factors for short- and long-term outcomes after aSAH.
No takes yet. Share an insight, caveat, or question.
Burzyńska et al. (2017) conducted a cohort in aneurysmal subarachnoid haemorrhage (aSAH) (n=104). Cardiac troponin I (cTnI) elevation and pulmonary disorders was evaluated on Short-term outcomes assessed by the Glasgow Outcome Scale (GOS) and Extended Glasgow Outcome Scale (GOSE) (AUC 0.741, p=<0.001). Cardiac troponin I elevation accurately predicted short-term outcomes (AUC 0.741, p<0.001) and 6-month outcomes (AUC 0.688, p=0.015) in patients with aneurysmal subarachnoid haemorrhage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: